Tokyo, Aug. 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058592) titled 'Ishinomaki Interstitial Lung Diseases Cohort Study' on Aug. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Japanese Red Cross Ishinomaki Hospital
Condition:
Condition - Interstitial lung diseases
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the clinical characteristics and outcomes of Japanese patients with interstitial lung diseases.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1) Aged 18 years or older at the time of enrollment.
2) Diagnosis of interstitial lung diseases confirmed by An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline 2022 and the corresponding guidelines for each diseases.
3) Ability to understand the study procedures and provide written informed consent.
Key exclusion criteria - 1) Patients who are not scheduled to undergo any of the tests in this study; 2) Patients who have undergone a lobectomy or greater by the time of enrollment; or 3) Patients who are deemed inappropriate by the principal investigator or subinvestigators for any other reason.
Target Size - 300
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 07 Month 04 Day
Date of IRB - 2025 Year 07 Month 07 Day
Anticipated trial start date - 2025 Year 08 Month 01 Day
Last follow-up date - 2030 Year 04 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066987
Disclaimer: Curated by HT Syndication.
